SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Iroko Pharmaceuticals Release: Novel, Submicron Particle, Lower-Dose Diclofenac Demonstrated Relief of Acute Pain in Phase 3 Study